Calibrate Health Review
Best for: patients with insurance coverage who want a year-long coaching-wrap around branded Wegovy / Zepbound / Foundayo
Calibrate Health (joincalibrate.com) is a year-long metabolic-reset weight-loss program built around branded GLP-1 medication (Wegovy, Ozempic, Zepbound, or Foundayo) plus 1:1 video coaching. Program fee is $199/month with a 12-month commitment ($597 quarterly billing); medication cost is separate (~$25/month with insurance via the manufacturer savings card, otherwise standard manufacturer pricing). Distinct from 'Oxford's Medical Weight Loss / The Calibrate Clinic' already in our directory — those are unrelated entities sharing the 'Calibrate' name.
High confidence · Last verified 2026-05-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Calibrate Health pairs medication with comprehensive coaching and support.
Score Breakdown
Drugs Offered
Calibrate Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Calibrate Year program fee (with insurance covering medication) | brand | $199 |
| Calibrate Year medication add-on (with insurance + savings card) | brand | $25 |
✓ Pros
- •Year-long structured program with 1:1 video coaching, registered-dietitian support, and curriculum-based behavior-change content — deeper clinical wrap than transactional telehealth providers
- •$199/month program fee is competitive for a coaching-included GLP-1 program; medication co-pay drops to ~$25/month with insurance + manufacturer savings card
- •Branded GLP-1s only (Wegovy, Ozempic, Zepbound, Foundayo) — no compounded products, no FDA gray-zone risk
- •Insurance navigation team works with patients to maximize coverage; reportedly accepts most major commercial plans
- •Money-back guarantee tied to weight-loss outcomes (10% reduction over the program year) signals confidence in the program model
- •Published 3-year outcomes data ('19% mean weight loss' per Calibrate's pricing page) is more transparent than most weight-loss programs
✗ Cons
- •12-month commitment with quarterly billing ($597 every 3 months) is a much higher financial lock-in than month-to-month telehealth providers — not refundable mid-program
- •Medication cost is on top of the $199/month program fee — cash-pay patients without insurance face full manufacturer pricing for Wegovy/Zepbound on top of the program fee, which makes the all-in cost meaningfully higher than compounded-GLP-1 telehealth providers
- •Insurance navigation depends on actually having coverage for branded GLP-1s for weight loss — most commercial plans still don't cover Wegovy/Zepbound for obesity without medical necessity
- •Program is structured around branded GLP-1s; if your insurance denies coverage and you need a more affordable channel, Calibrate is meaningfully more expensive than compounded telehealth alternatives
- •Distinct from 'Oxford's Medical Weight Loss (The Calibrate Clinic)' already in our directory — don't confuse the two when shopping
Ready to start with Calibrate Health?
Starting at $25/month. See current pricing and start your free consultation.
Sources & methodology
Our Calibrate Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to Calibrate Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Calibrate Health?
Starting at $25/month. See current pricing and start your free consultation.